Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome

Katia Rea(Fondazione IRCCS Istituto Nazionale dei Tumori), Antonella Tomassetti(Fondazione IRCCS Istituto Nazionale dei Tumori)

Oncotarget

September 4, 2015

10.18632/oncotarget.5087

Cited by 35

Related Papers

Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer

|Oncogene|2011|116

EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells

|Cell Death and Disease|2013|41